Ocular toxoplasmosis;Okuläre Toxoplasmose

Ophthalmologe

Volumn 104, Issue 7, 2007, Pages 603-616

  Pleyer, U ^a   Torun, N ^a   Liesenfeld, O ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Intraocular inflammation; Retinochoroiditis; Toxoplasma gondii; Uveitis

Indexed keywords

ANTIINFECTIVE AGENT; CORTICOSTEROID;

ARTICLE; CLINICAL PRACTICE; HUMAN; PRACTICE GUIDELINE; TOXOPLASMOSIS;

ADRENAL CORTEX HORMONES; ANTI-INFECTIVE AGENTS; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; TOXOPLASMOSIS, OCULAR;

EID: 34547455728     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00347-007-1535-8     Document Type: Article

References (86)

1. Acers TE (1964) Toxoplasmic retinochoroiditis: a double blind therapeutic study. Arch Ophthalmol 71: 58-62
2. Ajzenberg D, Cogne N, Paris L et al. (2002) Genotype of 86 Toxoplasma gondii isolates associated with human congenital toxoplasmosis, and correlation with clinical findings. J Infect Dis 186: 684-689
3. Bosch-Driessen LE, Berendschot TT, Ongkosuwito JV et al. (2002) Ocular toxoplasmosis: clinical features and prognosis of 154 patients. Ophthalmology 109: 869-878
4. Burnett AJ, Shortt SG, Isaac-Renton J et al. (1998) Multiple cases of acquired toxoplasmic retinitis presenting in an outbreak. Ophthalmology 105: 1032-1037
5. Chapman DJ, Ashburn D, Ogston SA et al. (1999) The relationship between ocular toxoplasmosis and levels of specific Toxoplasma antobodies. Epidemiol Infect 122: 299-303
6. Cochereau-Massin I, LeHoang P, Lautier-Frau M et al. (1992) Ocular toxoplasmosis in human immunodeficiency virus-infected patients. Am J Ophthalmol 114: 130-135
7. Cornelissen AW, Overdulve JP, Ploeg M van der (1984) Determination of nuclear DNA of five eucoccidian parasites, Isospora (Toxoplasma) gondii, Sarcocystis cruzi, Eimeria tenella, E acervulina and Plasmodium berghei, with special reference to gamontogenesis and meiosis in I. (T.) gondii. Parasitology 88: 531-553
8. Dobrowolski JM, Sibley LD (1996) Toxoplasma invasion of mammalian cells is powered by the actin cytoskeleton of the parasite. Cell 84: 933-939
9. Dubey JP, Miller NL, Frenkel JK (1970) The Toxoplasma gondii oocyst from cat feces. J Exp Med 132: 636-662
10. Dunn D, Wallon M, Peyron F et al. (1999) Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 353: 1829-1833
11. Dutton GN, McMenamin PG, Hay J et al. (1986) The ultrastructural pathology of congenital murine toxoplasmic retinochoroiditis. Part II: The morphology of the inflammatory changes. Exp Eye Res 43: 545-560
12. Engstrom RE Jr, Holland GN, Nussenblatt RB et al. (1991) Current practices in the management of ocular toxoplasmosis. Am J Ophthalmol 111: 601-610
13. Feron EJ, Klaren VN, Wierenga EA et al. (2001) Characterization of Toxoplasma gondii-specific T cells recovered from vitreous fluid of patients with ocular toxoplasmosis. Invest Ophthalmol Vis Sci 42: 3228-3232
14. Fish RH, Hoskins JC, Kline LB (1993) Toxoplasmosis neuroretinitis. Ophthalmology 100: 1177-1182
15. Folk JC, Lobes LA (1984) Presumed toxoplasmic papillitis. Ophthalmology 91: 64-67
16. Forsgren M, Gille E, Ljungstrom I et al. (1991) Toxoplasma gondii antibodies in pregnant women in Stockholm in 1969, 1979, and 1987. Lancet 337: 1413-1414
17. Fox BA, Bzik DJ (2002) De novo pyrimidine biosynthesis is required for virulence of Toxoplasma gondii. Nature 415: 926-929
18. Frenkel JK (1973) Toxoplasmosis: parasite life cycle pathology and immunology. In: Hammond DM, Long PL (Eds) The Coccidia. University Park Press, Baltimore, pp 343-410
19. Frenkel JK, Dubey JP, Miller N L et al. (1970) Toxoplasma gondii: a coccidian of cats, with a wide range of mammalian and avian intermediate hosts. J Parasitol 56: 107-108
20. Friedmann CT, Knox DL (1969) Variations in recurrent active toxoplasmic retinochoroiditis. Arch Ophthalmol 81: 481-493
21. Gagliuso DJ, Teich SA, Friedman AH et al. (1990) Ocular toxoplasmosis in AIDS patients. Trans Am Ophthalmol Soc 88: 63-86
22. Garweg JG (2005) Determinants of immunodiagnostic success in human ocular toxoplasmosis. Parasite Immunol 27: 61-68
23. Gaynon MW, Boldrey EE, Strahlman ER et al. (1984) Retinal neovascularization and ocular toxoplasmosis. Am J Ophthalmol 98: 585-589
24. Gazzinelli RT, Brezin A, Li Q et al. (1994) Toxoplasma gondii: acquired ocular toxoplasmosis in the murine model, protective role of TNF-alpha and IFN-gamma. Exp Parasitol 78: 217-229
25. Gazzinelli RT, Wysocka M, Hieny S et al. (1996) In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J Immunol 157: 798-805
26. Georgiev VS (1994) Management of toxoplasmosis. Drugs 48: 179-188
27. Gilbert RE, Dunn DT, Lightman S et al. (1999) Incidence of symptomatic toxoplasma eye disease: aetiology and public health implications. Epidemiol Infect 123: 283-289
28. Gilbert RE, Stanford MR (2000) Is ocular toxoplasmosis caused by prenatal or postnatal infection? Br J Ophthalmol 84: 224-226
29. Glasner PD, Silveira C, Kruszon-Moran D et al. (1992) An unusually high prevalence of ocular toxoplasmosis in Southern Brazil. Am J Ophthalmol 114: 136-144
30. Goldmann H, Witmer R (1957) Antikörper im Kammerwasser. Ophthalmologica 127: 323-330
31. Grigg ME, Ganatra J, Boothroyd JC et al. (2001) Unusual abundance of atypical strains associated with human ocular toxoplasmosis. J Infect Dis 184: 633-639
32. Grigg ME, Bonnefoy S, Hehl AB et al. (2001) Success and virulence in Toxoplasma as the result of sexual recombination between two distinct ancestries. Science 294: 161-165
33. Guerina NG, Hsu HW, Meissner HC et al. (1994) Neonatal serological screening and early treatment for congenital Toxoplasma gondii infection. N Engl J Med 330: 1858-1863
34. Hogan MJ (1961) Ocular toxoplasmosis in adult patients. Surv Ophthalmol 6: 935-951
35. Hogan MJ, Kimura SJ, O'conner GR (1964) Ocular toxoplasmosis. Arch Ophthalmol 72: 592-600
36. Holland GN (2003) Ocular toxoplasmosis: a global reassessment. Part I: Epidemiology and course of disease. Am J Ophthalmol 136: 973-988
37. Holland GN (2004) Ocular toxoplasmosis: a global reassessment. Part II: Disease manifestations and management. Am J Ophthalmol 137: 1-17
38. Holland GN, O'Connor GR, Belfort R et al. (1996) Toxoplasmosis. In: Pepose JS, Holland GN, Wilhelmus KR (Eds) Ocular infection & immunity. Mosby-Year Book Inc., St. Louis, Missouri, pp 1183-1223
39. Howe DK, Sibley DL (1995) Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. J Infect Dis 172: 1561-1566
40. Hutchison WM (1965) Experimental transmission of Toxoplasma gondii. Nature 206: 961-962
41. Hutchison WM, Dunachie et al. (1970) Coccidian-like nature of Toxoplasma gondii. BMJ 1: 142-144
42. Janitschke K (1991) Toxoplasmose. In: Hahn H, Falke D, Klein P (Hrsg) Medizinische Mikrobiologie. Springer, Berlin Heidelberg New York, S 898-900
43. Janku J (1959) Die Pathogenese und pathologische Anatomie des sogenannten angeborenen Koloboms des gelben Flecks im normal grossen sowie mikrophthalmischen Auge mit Parasitenbefund in der Netzhaut. Cls Parasit 6: 9-16
44. Joynson DH (1992) Epidemiology of toxoplasmosis in the U.K. Scand J Infect Dis Suppl 84: 65-69
45. Khan A, Jordan C, Muccioli C et al. (2006) Genetic divergence of Toxoplasma gondii strains associated with ocular toxoplasmosis, Brazil. Emerg Infect Dis 12: 942-949
46. Kong JT, Grigg ME, Uyetake L et al. (2003) Serotyping of Toxoplasma gondii infections in humans using synthetic peptides. J Infect Dis 187: 1484-1495
47. Koppe JG, Loewer-Sieger DH, Roever-Bonnet H de (1986) Results of 20-year follow-up of congenital toxoplasmosis. Lancet 1: 254-256
48. Labelette P, Delhaes L, Margaron F et al. (2002) Ocular toxoplasmosis after the fifth decade. Am J Ophthalmol 133: 506-515
49. Lebech M, Andersen O, Christensen NC et al. (1999) Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Danish Congenital Toxoplasmosis Study Group. Lancet 353: 1834-1837
50. Lehmann T, Blackston CR, Parmley SF et al. (2000) Strain typing of Toxoplasma gondii: comparison of antigen-coding and housekeeping genes. J Parasitol 86: 960-971
51. Liesenfeld O, Kosek J, Remington JS et al. (1996) Association of CD4+ T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii. J Exp Med 184: 597-607
52. Maetz HM, Kleinstein RN, Federico D et al. (1987) Estimated prevalence of ocular toxoplasmosis and toxocariasis in Alabama. J Infect Dis 156: 414
53. McMenamin PG, Dutton GN, Hay J et al. (1986) The ultrastructural pathology of congenital murine toxoplasmic retinochoroiditis. Part I: The localization and morphology of Toxoplasma cysts in the retina. Exp Eye Res 43: 529-543
54. Meek B, Klaren VN, Haeringen NJ van et al. (2000) IgA antibodies to Toxoplasma gondii in human tears. Invest Ophthalmol Vis Sci 41: 2584-2590
55. Meissner M, Schluter D, Soldati D (2002) Role of Toxoplasma gondii myosin A in powering parasite gliding and host cell invasion. Science 298: 837-840
56. Mine N (1911) Observation on protozoan parasites in Japan. Gun-I-Dan Zasshi 27: 1-3
57. Montoya JG, Remington JS (1996) Toxoplasmic chorioretinitis in the setting of acute acquired toxoplasmosis. Clin Infect Dis 23: 277-282
58. Montoya JG, Liesenfeld O (2004) Toxoplasmosis. Lancet 363: 1965-1976
59. Muccioli C, Belfort R (2006) Ocular Toxoplasmosis. In: Pleyer U, Foster CS (Eds) Uveitis and Immunological Disorders. Springer, Berlin
60. Nicolle C, Maneaux L (1909) Sur une proizare nouveau du gondi (Toxoplasma n.g.). Arch Inst Pasteur Tunis 4: 97-100
61. Ongkosuwito JV, Feron EJ, Doornik CE van et al. (1998) Analysis of immunoregulatory cytokines in ocular fluid samples from patients with uveitis. Invest Ophthalmol Vis Sci 39: 2659-2665
62. Ongkosuwito JV, Bosch-Driessen EH, Kijlstra A et al. (1999) Serologic evaluation of patients with primary and recurrent ocular toxoplasmosis for evidence of recent infection. Am J Ophthalmol 128: 407-412
63. Pavesio CE, Lightman S (1996) Toxoplasma gondii and ocular toxoplasmosis: pathogenesis. Br J Ophthalmol 80: 1099-1107
64. Perkins ES, Smith CH, Schofield PB (1956) Treatment of Uveitis with pyrimethamine (Daraprim). Br J Ophthalmol 40: 577-586
65. Perkins ES (1973) Ocular toxoplasmosis. Br J Ophthalmol 57: 1-17
66. Quentin CD, Reiber H (1997) Kammerwasseranalytik bei intraokularer Toxoplasmose. Ophthalmologe 94: 728-731
67. Remky H (Ed) (1962) Toxoplasmosis. Argumenta et documenta ophthalmologica. J. F. Lehmanns, München
68. Ronday MJH, Stilma JS, Barbe RF et al. (1996) Aetiology of uveitis in Sierra Leone, West Africa. Br J Ophthalmol 80: 956-961
69. Ronday MJH, Ongkosuwito JV, Rothova A et al. (1999) Intraocular anti-Toxoplasma gondii IgA antibody production in patients with ocular toxoplasmosis. Am J Ophthalmol 127: 294-300
70. Rothova A, Meenken C, Buitenhuis HJ et al. (1993) Therapy for ocular toxoplasmosis. Am J Ophthalmol 115: 517-523
71. Ruete CGT (1854) Bildliche Darstellung der Krankheiten des menschlichen Auges. B. G. Teubner, Leipzig
72. Sibley LD, Boothroyd JC (1992) Virulent strains of Toxoplasma gondii comprise a single clonal lineage. Nature 359: 82-85
73. Silveira C, Belfort R Jr, Muccioli C et al. (2002) The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. Am J Ophthalmol 134: 41-46
74. Smith KL, Wilson M, Hightower AW et al. (1996) Prevalence of Toxoplasma gondii antibodies in US military recruits in 1989: comparison with data published in 1965. Clin Infect Dis 23: 1182-1183
75. Splendore A (1908) Uno nuovo protozoa parasite die conigli: incontrato nelle lesioni anatomiche dúna malattia che ricorda in molti punti il Kala-azar dell uomo. Rev Soc Sci Sao Paolo 3: 109-112
76. Stanford MR, See SE, Jones LV et al. (2003) Antibiotics for toxoplasmic retinochoroiditis: an evidence-based systematic review. Ophthalmology 110: 926-931
77. Suzuki Y, Sher A, Yap G et al. (2000) IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following peroral infection with Toxoplasma gondii. J Immunol 164: 5375-5382
78. Torun N, Liekfeld A, Hartmann C et al. (2002) Okuläre Toxoplasmose-Antikörper in Kammerwasser und Serum. Ophthalmologe 99: 109-112
79. Tran VT, Auer C, Guex-Crosier Y et al. (1994) Epidemiological characteristics of uveitis in Switzerland. Int Ophthalmol 18: 293-298
80. Wallon M, Kodjikian L, Binquet C et al. (2004) Long-term ocular prognosis in 327 children with congenital toxoplasmosis. Pediatrics 113: 1567-1572
81. Weiland H, Kühn D (1970) Experimentelle Toxoplasma-Infektionen bei der Katze. II. Entwicklungsstadien des Parasiten im Darm. Berl Munch Tierarztl Wochenschr 83: 128-132
82. Weinman D, Chandler AH (1956) Toxoplasmosis in man and swine - an investigation of the possible relationship. JAMA 161: 229-232
83. Witmer RH (1955) Ätiologische Diagnostik der Uveitis. Graefes Arch Clin Exp Ophthalmol 156: 235-260
84. Wolf A, Cowen D, Paige BH (1939) Human toxoplasmosis. Occurence in infants as an encephalomyelitis. Verification bytransmission to animals. Science 89: 226-227
85. Zangerle R, Allerberger F, Pohl P et al. (1991) High risk of developing toxoplasmic encephalitis in AIDS patients seropositive to Toxoplasma gondii. Med Microbiol Immunol 180: 59-66
86. Zuber P, Jacquier P (1995) Epidémiologie de la toxoplasmose: situation au niveau mondial. Schweiz Med Wochenschr (Suppl 65) 125: 19S-22S